Literature DB >> 15950278

Mechanism of bone incorporation of beta-TCP bone substitute in open wedge tibial osteotomy in patients.

Robert D A Gaasbeek1, Hanneke G Toonen, Ronald J van Heerwaarden, Pieter Buma.   

Abstract

A histological study was performed of bone biopsies from 16 patients (17 biopsies) treated with open wedge high tibial osteotomies for medial knee osteoarthritis. The open wedge osteotomies were filled with a wedge of osteoconductive beta tricalcium phosphate (beta-TCP) ceramic bone replacement. At the time of removal of the fixation material, core biopsies of the area where the beta-TCP was located were taken at different follow-up periods (6-25 months). beta-TCP resorption, bone ingrowth and bone remodelling were studied. We hypothesized that the incorporation and remodelling process occurs similarly as in animals. Histology showed a good resorption of the beta-TCP with complete incorporation and remodelling into new bone. The different phases as described in animal studies were found. A correlation was found between histological findings and radiological assessment. In conclusion, beta-TCP appeared to be a bone replacement material with optimal biocompatibility, resorption characteristics and bone conduction properties for the clinical use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950278     DOI: 10.1016/j.biomaterials.2005.04.056

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  29 in total

1.  Opening wedge high tibial osteotomy using 3D biomodelling Bonelike macroporous structures: case report.

Authors:  M Gutierres; A G Dias; M A Lopes; N Sooraj Hussain; A T Cabral; L Almeida; J D Santos
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

Review 2.  Results of high tibial osteotomy: review of the literature.

Authors:  Annunziato Amendola; Davide Edoardo Bonasia
Journal:  Int Orthop       Date:  2009-10-17       Impact factor: 3.075

3.  Evaluation of OSSIFI® as Alloplastic Bone Graft Material in Treatment of Periodontal Infrabony Defects.

Authors:  Sumit Kaushal; Anoop Kapoor; Preetinder Singh; Gulsheen Kochhar; Nitin Khuller; Patthi Basavaraj
Journal:  J Clin Diagn Res       Date:  2014-10-20

4.  Opening wedge high tibial osteotomy: plate position and biomechanics of the medial tibial plateau.

Authors:  Pilar Martinez de Albornoz; Manuel Leyes; Francisco Forriol; Angelo Del Buono; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-30       Impact factor: 4.342

5.  Distal femoral osteotomy.

Authors:  Federica Rosso; Fabrizio Margheritini
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

6.  3D printed β-TCP bone tissue engineering scaffolds: Effects of chemistry on in vivo biological properties in a rabbit tibia model.

Authors:  Samit Kumar Nandi; Gary Fielding; Dishary Banerjee; Amit Bandyopadhyay; Susmita Bose
Journal:  J Mater Res       Date:  2018-07-27       Impact factor: 3.089

Review 7.  High Tibial Osteotomy: A Systematic Review and Current Concept.

Authors:  Soheil Sabzevari; Adel Ebrahimpour; Mostafa Khalilipour Roudi; Amir R Kachooei
Journal:  Arch Bone Jt Surg       Date:  2016-06

8.  Oxidatively Degradable Poly(thioketal urethane)/Ceramic Composite Bone Cements with Bone-Like Strength.

Authors:  Madison A P McEnery; Sichang Lu; Mukesh K Gupta; Katarzyna J Zienkiewicz; Joseph C Wenke; Kerem N Kalpakci; Daniel Shimko; Craig L Duvall; Scott A Guelcher
Journal:  RSC Adv       Date:  2016-11-08       Impact factor: 3.361

9.  The use of beta-TCP in the surgical treatment of tibial plateau fractures.

Authors:  Chao Shen; Jie Ma; Xiao-Dong Chen; Li-Yang Dai
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-02-24       Impact factor: 4.342

10.  Calcium phosphate cement enhances primary stability of open-wedge high-tibial osteotomies.

Authors:  Thomas Lind-Hansen; Poul Torben Nielsen; Juozas Petruskevicius; Benny Endelt; Karl Brian Nielsen; Ivan Hvid; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-07-24       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.